The first agreement is with PPMT Strategic Group, Inc, ('PPMT") a strategic consulting group with widespread capabilities that include, Mergers & Acquisitions advisory services, Sales and Marketing, Industry Partnering, Compliance and Executive CFO services and much more. PPMT is expected to gain access on behalf of Lexaria to potential industry partners in the sectors where Lexaria's technology holds immense promise: such as generic vitamins and supplements and pain medications, as well as other sectors.
PPMT offers a wide range of business advisory capabilities designed to augment the management functions of Microcap Companies and their Board of Directors. In entering this agreement Lexaria has significantly enhanced its Management breath of expertise in a cost effective manner. Lexaria expects PPMT to introduce the Lexaria Technology and Products to their network of business relationships that are mutually beneficial and lead toward much higher awareness and visibility for Lexaria's products and technology.
"We are excited to work with the Lexaria team to accelerate the introduction of their technology to the market. We believe that Lexaria Technology has the potential to disrupt the nutraceutical and the OTC sectors." said Wesley Ramjeet, CEO of PPMT Strategic Group.
The second agreement is with Terra Nova Capital Partners, Inc, a boutique investment and merchant banking firm with global reach. Established in 1999, the firm has led or participated in capital raises and/or financings of over $465 million since 2003, and is a FINRA registered broker-dealer. Terra Nova reaches a global network of over 28 countries and will be providing Lexaria with advice, support and expertise with its capital needs for the 12-month term of the engagement.
Terra Nova is a leading advisor to micro-cap public companies in private placements and other forms of company financing, and is part of the Global Alliance Partners network which has collectively completed over $33 billion in over 1,000 corporate transactions.
"We couldn't be more pleased than to be working with such reputable and capable firms as Terra Nova and PPMT Group," said Chris Bunka, CEO of Lexaria. "These new relationships will strengthen Lexaria in many ways and focus on immediate and achievable targets that will build our brands and our business."
PPMT will receive 250,000 restricted common shares as initial payment under the agreement. PPMT will receive 250,000 warrants to purchase common shares each month until the end of the agreement, with a fixed floor price and otherwise subject to normal regulatory conditions.
The securities issued will be subject to a hold period for any resales into the USA under Rule 144 of six months and one day. All share and warrant issuances will be subject to normal regulatory approvals.
The securities referred to herein will not be or have not been registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.
About Lexaria
Lexaria Bioscience Corp. is a food sciences company focused on the delivery of active compounds that can behave as superfoods through its proprietary infusion technologies. Lexaria's technology enables higher bioavailability rates for CBD; THC; NSAIDs; Nicotine and other molecules than is possible without lipophilic enhancement technology. This can allow for lower overall dosing requirements and/or higher effectiveness in active molecule delivery. Lexaria hopes to reduce other common but less healthy ingestion methods such as smoking as it embraces the benefits of public health. www.lexariaenergy.com